Pharmaceutical News

RSS

Raptor Pharmaceuticals initiates phase IIa clinical study for Convivia

Raptor Pharmaceuticals Corp. has announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc. , has initiated the Company's first clinical-stage program after dosing the first cohort in a Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.

21 Apr 2008

Dental sealants still offer best protection against tooth decay says the BC Dental Association

Dental sealants remain one of the best methods for protection against tooth decay in children, says the BC Dental Association. The Association supports Health Canada's announcement that bisphenol-A (BPA) in dental resin materials poses no significant health threat.

20 Apr 2008

Pharmaceutical Care Management Association response to New York Times article on biotech medicine costs

The Pharmaceutical Care Management Association (PCMA) issued the following statement today regarding a story to be published in tomorrow's New York Times.

18 Apr 2008

Sen. Grassley sends letter to Merck requesting explanation of recent JAMA reports

Sen. Chuck Grassley (R-Iowa) has sent a letter to Merck Chief Operating Officer Richard Clark requesting the company explain a recent report that found the company used employees or paid consultants rather than the physicians listed as lead authors to write several published studies of the COX-2 inhibitor Vioxx, CQ HealthBeat reports.

18 Apr 2008

Draft legislation aimed at overhauling FDA would require more inspections, change user fees

House Energy and Commerce Committee Chair John Dingell (D-Mich.) on Thursday released draft legislation that would make broad regulatory changes to FDA and increase funds for the agency, CQ Today reports.

18 Apr 2008

Drug company coalition to push for looser rules on off-label marketing

Representatives of health care marketing firms, patient advocacy groups and pharmaceutical companies this week are in Washington, D.C., to express support for loosening rules regarding drug companies' ability to market medications for off-label uses, the Wall Street Journal reports (Mundy, Wall Street Journal, 4/18).

18 Apr 2008

Aida Pharmaceuticals announces development of new anti-cancer drug

Aida Pharmaceuticals, Inc. has announced that it is developing a potential cancer drug that seeks to trigger cell death in certain types of cancer.

18 Apr 2008

Interaction networks: the new path to drug discovery

Although the pharmaceutical industry has dedicated enormous research efforts over the last 50 years to identify new targets and develop new active ingredients, these efforts have met with limited success.

17 Apr 2008

Unbiased, comprehensive analysis of drug research from new web site

Physicians and consumers who want fair and balanced information about the most appropriate uses for prescription medications can now find it using a Web-based resource that provides easily accessible, science-based research about drug uses free from pharmaceutical industry influence.

17 Apr 2008

New type of drug shrinks primary breast cancer tumours significantly in just six weeks

A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use, a scientist told the 6th European Breast Cancer Conference (EBCC-6) (Thursday 17 April).

17 Apr 2008

2nd Alzheimer's vaccine by AFFiRiS

The Viennese biotech company Affiris is today taking stock of the progress achieved to date in its clinical Alzheimer's vaccination programme. All the Alzheimer's patients treated so far as part of the toxicological trials have tolerated the treatment extremely well. As a result, Affiris is among the leading international centres in the race to develop the first causal immunotherapy for Alzheimer's disease.

17 Apr 2008

Drugs in the pipeline: new therapies that could change treatment strategies

The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.

16 Apr 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

Promising Australian cancer drug on show in the U.S.

A cancer drug in the process of being developed by two Australian companies has shown promising results in preliminary trials on animals.

16 Apr 2008

Global Alliance for Pharmacogenomics

Leaders at the National Institutes of Health and the Center for Genomic Medicine in Japan have signed a letter of intent creating a Global Alliance for Pharmacogenomics.

15 Apr 2008

Popular painkiller Nurofen Plus in danger of becoming a prescription only drug

Australia's National Drugs and Poisons Scheduling Committee (NDPSC) is apparently considering making one of the most commonly used over-the-counter (OTC) drugs available only with a prescription.

15 Apr 2008

New mucosal vaccine against anthrax effective in early tests

Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a "popular" bioweapon, according to a study published in the journal Clinical and Vaccine Immunology (CVI).

13 Apr 2008

Takeda to acquire Millennium for $8.8 billion

Takeda Pharmaceutical Company Limited and Millennium Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement pursuant to which Takeda will acquire Millennium for approximately $8.8 billion through a cash tender offer of $25.00 per share.

10 Apr 2008

Over-the-counter sale of child cough medicine for young children to be banned

As from September this year the over-the-counter sale of cough medicines for children under the age of two years old will be banned in Australia.

9 Apr 2008

New method to detect fake Tamiflu

Chemists in Georgia are reporting development of a fast new method to detect fake Tamiflu, the mainstay medication for preventing and treating bird flu.

8 Apr 2008